RhumbLine Advisers
ASPX

RhumbLine Advisers’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

RhumbLine Advisers’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,890
Closed -$992K – 3192
2015
Q1 		$992K Buy
9,890
+3,285
+50% +$219K ﹤0.01% 1862
2014
Q4 		$347K Buy
+6,605
New +$194K ﹤0.01% 2499

RhumbLine Advisers's ASPX Position: Q2 2015 in Review

RhumbLine Advisers sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 9,890 shares — an estimated $992K sold.

RhumbLine Advisers first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $992K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • RhumbLine Advisers reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • RhumbLine Advisers sold 9,890 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $992K.
  • RhumbLine Advisers first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • RhumbLine Advisers's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $992K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on RhumbLine Advisers's 13F filing for Q2 2015, filed 4 Aug 2015.